Oculis Holding AG (OCS) Other financing activities (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Other financing activities came in at $614239.3 in Q1 2026, up 75.88% year-on-year from $349246.7 in Q1 2025, and up 102.03% quarter-over-quarter from $304034.3 in Q4 2025.

Oculis Holding AG (OCS) Other financing activities (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other financing activities history runs 5 years deep, the most recent figure standing at $614239.3 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 75.88% year-over-year to $614239.3 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 117.07% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 114.48% from the prior year.
  • Other financing activities rose to $614239.3 in Q1 2026 per OCS's latest filing, from $304034.3 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.6 million in Q2 2025 and bottomed at -$398517.7 in Q3 2023.
  • The 5-year median for Other financing activities is $203867.5 (2023), against an average of $310164.4.
  • Biggest YoY gain for Other financing activities was 3929.48% in 2025; the steepest drop was 98.02% in 2025.
  • Year by year, Other financing activities stood at $8304.2 in 2022, then soared by 1692.0% to $148810.8 in 2023, then tumbled by 42.47% to $85614.1 in 2024, then surged by 255.12% to $304034.3 in 2025, then surged by 102.03% to $614239.3 in 2026.
  • Per Business Quant, the three latest OCS Other financing activities figures stand at $614239.3 (Q1 2026), $304034.3 (Q4 2025), and $13751.2 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 614,239.25
Mar 31, 2026 614,239.25
Dec 31, 2025 304,034.26
Dec 31, 2025 304,034.26
Sep 30, 2025 13,751.20
Sep 30, 2025 13,751.20
Jun 30, 2025 1.60 Mn
Jun 30, 2025 1.60 Mn
Mar 31, 2025 349,246.67
Mar 31, 2025 349,246.67
Dec 31, 2024 85,614.14
Dec 31, 2024 85,614.14
Sep 30, 2024 693,678.55
Sep 30, 2024 693,678.55
Jun 30, 2024 39,808.57
Jun 30, 2024 39,808.57
Mar 31, 2024 258,924.20
Mar 31, 2024 258,924.20
Dec 31, 2023 148,810.79
Dec 31, 2023 148,810.79